JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (14)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fiechtner, B. K.
Right arrow Articles by Ereth, M. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fiechtner, B. K.
Right arrow Articles by Ereth, M. H.
Related Collections
Right arrow Surgery
Right arrow Monitoring (Cardiac)
Anesth Analg 2001;92:1131-1136
© 2001 International Anesthesia Research Society

CARDIOVASCULAR ANESTHESIA

Plasma Tranexamic Acid Concentrations During Cardiopulmonary Bypass

Bridget K. Fiechtner, MD*, Gregory A. Nuttall, MD*, Michael E. Johnson, MD, PhD*, Yue Dong, MD*, Nuntiya Sujirattanawimol, MD*, William C. Oliver, Jr., MD*, Rajbir S. Sarpal, MD{dagger}, Lance J. Oyen, PharmD, BCPS*, and Mark H. Ereth, MD*

*Mayo Graduate School of Medicine, Rochester, Minnesota; and {dagger}Department of Biology, University of Wisconsin Critical Care, Madison, Wisconsin

Address correspondence and reprint requests to Gregory A. Nuttall, MD, Department of Anesthesiology, Mayo Clinic, Rochester, MN 55905. Address e-mail to nuttall.gregory{at}mayo.edu

Although tranexamic acid is used to reduce bleeding after cardiac surgery, there is large variation in the recommended dose, and few studies of plasma concentrations of the drug during cardiopulmonary bypass (CPB) have been performed. The plasma tranexamic acid concentration reported to inhibit fibrinolysis in vitro is 10 µg/mL. Twenty-one patients received an initial dose of 10 mg/kg given over 20 min followed by an infusion of 1 mg · kg-1 · h-1 via a central venous catheter. Two patients were removed from the study secondary to protocol violation. Perioperative plasma tranexamic acid concentrations were measured with high-performance liquid chromatography. Plasma tranexamic acid concentrations (µg/mL; mean ± SD [95% confidence interval]) were 37.4 ± 16.9 (45.5, 29.3) after bolus, 27.6 ± 7.9 (31.4, 23.8) after 5 min on CPB, 31.4 ± 12.1 (37.2, 25.6) after 30 min on CPB, 29.2 ± 9.0 (34.6, 23.8) after 60 min on CPB, 25.6 ± 18.6 (35.1, 16.1) at discontinuation of tranexamic acid infusion, and 17.7 ± 13.1 (24.1, 11.1) 1 h after discontinuation of tranexamic acid infusion. Four patients with renal insufficiency had increased concentrations of tranexamic acid at discontinuation of the drug. Repeated-measures analysis revealed a significant main effect of abnormal creatinine concentration (P = 0.02) and time (P < 0.001) on plasma tranexamic acid concentration and a significant time x creatinine concentration interaction (P < 0.001).

Implications: A 10 mg/kg initial dose of tranexamic acid followed by an infusion of 1 mg·kg-1·h-1produced plasma concentrations throughout the cardiopulmonary bypass period sufficient to inhibit fibrinolysis in vitro. The dosing of tranexamic acid may require adjustment for renal insufficiency.




This article has been cited by other articles:


Home page
 Anesth. Analg.Home page
M. P. Eaton
Antifibrinolytic Therapy in Surgery for Congenital Heart Disease
Anesth. Analg., April 1, 2008; 106(4): 1087 - 1100.
[Abstract] [Full Text] [PDF]

Home page
 Asian Cardiovasc. Thorac. Ann.Home page
M. M Maddali and M. C Rajakumar
Tranexamic Acid and Primary Coronary Artery Bypass Surgery: a Prospective Study
Asian Cardiovasc Thorac Ann, August 1, 2007; 15(4): 313 - 319.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
G. J. Murphy, E. Mango, V. Lucchetti, F. Battaglia, D. Catapano, C. A. Rogers, and G. D. Angelini
A randomized trial of tranexamic acid in combination with cell salvage plus a meta-analysis of randomized trials evaluating tranexamic acid in off-pump coronary artery bypass grafting.
J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 475 - 480.e8.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
J. J. Andreasen and C. Nielsen
Prophylactic tranexamic acid in elective, primary coronary artery bypass surgery using cardiopulmonary bypass
Eur. J. Cardiothorac. Surg., August 1, 2004; 26(2): 311 - 317.
[Abstract] [Full Text] [PDF]


Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 2001 by the International Anesthesia Research Society.